How can medical technology companies clearly explain product capabilities and the limits of their use?

Define the audience and intended use first

Users of medical technology products may include patients, healthcare professionals, procurement teams, and service personnel. Each audience needs to know what tasks the product is intended for, the conditions under which it can be used, and when professional judgment is required. Companies should first confirm the approved intended use and what information may be made public, then organize their marketing and explanatory content accordingly.

Inspired by public discussions at CES on trust and transparency in intelligent content, this article offers independent information design recommendations. Regulatory matters, compliance, clinical evidence, and risk disclosures for medical products must be reviewed by appropriately qualified professionals in accordance with applicable requirements.

Link capability descriptions to evidence

For each key capability, record the product model, software version, evidence sources, evaluation conditions, responsible person, and disclosure status. Performance results need to specify the relevant populations, settings, and test conditions. Early research, individual cases, or internal demonstrations must not be presented as conclusions that apply to all patients.

Distinguish between uses that have been approved or validated, areas under investigation, and future plans. Product names, certification information, scope of use, and limitations must accurately correspond to the relevant entity and current status.

If the product provides supporting information or recommendations, clearly state whether review by a healthcare professional is required. Interfaces and promotional language must not imply that the product has diagnostic or treatment capabilities that have not been validated.

Layer information according to readers' needs

Patient-facing information should explain the product's purpose, main steps, precautions, and contact methods in clear language. Materials for professionals may provide further specifications, evidence, and technical context. Different versions should draw on the same underlying facts and must not change the limits of use.

Important risks and limitations should appear where readers can find them. They must not be hidden in hard-to-read footers or provided only through verbal explanations. Charts should identify units, samples, or conditions of use to prevent misinterpretation.

When citing research or guidelines, link to the specific original sources and state their scope and publication dates. Cited material cannot replace a company's evaluation of its own product.

Explain data handling and human support

If a product processes health information or other sensitive data, explain its actual purposes, who can access it, how it is retained, and what controls are available. These explanations should be reviewed against the company's actual practices and applicable rules. Do not promise data protection capabilities that have not yet been implemented.

Clearly explain how to contact medical or technical support, which issues must be handled by professionals, and what to do next when an issue cannot be resolved online. Intelligent assistants must not make unsupported diagnostic or treatment promises to users.

When the system is uncertain, a device malfunctions, or information is insufficient, the interface should provide accurate messages and a safe way to seek help. Specific risk controls should be determined by the professional team.

Establish an ongoing review and update process

Before content is published, product, clinical, regulatory, or other appropriate responsible personnel should review the facts, evidence, uses, and wording, and record the version, approver, and review date. When the product changes, evidence is updated, or authorizations are adjusted, promptly check the relevant pages, manuals, and sales materials.

Ask target readers to explain the product's purpose and limitations, and observe whether misunderstandings occur. Feedback from testing cannot replace professional validation. Qingmei Future can assist with information architecture and brand content design; the company's professionals remain responsible for medical judgments, evidence, risk, and compliance.

For example, ask readers who were not involved in the project to review the product page and explain its purpose and the situations in which it should not be used. Product leads and the relevant professional leads should then check whether those readers' understanding aligns with the approved materials. If misunderstandings arise, first review the headings, qualifying conditions, and placement of information on the page.

Maintain version records to ensure outdated promotional materials are withdrawn from use or clearly marked with their validity period.

When customer service receives questions beyond the scope of publicly available information, there should be a process for escalating them to the professional team.

Discussion Background and Scope

CES · AI or Human? Trust, Transparency, and Co-Creation in the Age of Intelligent Content · 2026-01-07. Official page date: 2026-01-07. The source discusses authenticity, transparency and accountability in intelligent content. It is background reading, not evidence for each practical recommendation in this article. The recommendations are Qingmei Future’s independent analysis.

Related Services and Content

Explore digital interface design　Explore brand strategy services　Discuss digital product experience